274967 QbD Drug Substance Development At Bristol-Myers Squibb

Tuesday, October 30, 2012: 4:30 PM
Allegheny II (Westin )
Jose Tabora, Bristol-Myers Squibb Company, New Brunswick, NJ

TBD

Extended Abstract: File Not Uploaded